Real-world characteristics and outcomes of patients with advanced non-small cell lung cancer (aNSCLC) receiving immune checkpoint inhibitor

2019
Khozin S, Zhi J, Jun M, Chen L, Rubinstein WS, Walker MS, Komatsoulis GA, Roberts J, Fukushima R, Lau D, Hyde B, Stepanski E, Miller RS
Read more